Astria Therapeutics Inc. (ATXS), a biopharmaceutical company developing life-changing therapies for rare and niche allergic and immunological diseases, has a clinical trial catalyst to watch this quarter.
The company's lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein for the preventative treatment of Hereditary Angioedema (HAE), a rare genetic disorder characterized by severe, unpredictable, sometimes life-threatening swelling.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.